Statistics for Kronos Bio (id:8381 KRON)
Valuation metrics
Market cap
52.76M
Enterprise value
-58,203,288.00
Trailing P/E (ttm)
-0.46
Forward P/E
-0.63
PEG ratio
-0.63
Price/Sales (ttm)
6.27
Price/Book (mrq)
0.32
Enterprise Value/Revenue
-6.92
Enterprise Value/EBITDA
0.62
Overview
Shares outstanding
60.34M
Float
42.92M
Shares short
527.68K
% Held by insiders
0.27%
% Held by institutions
0.33%
Average volume (10 days)
299.84K
Average volume (90 days)
Price summary
52-Week low
0.69
52-Week high
1.60
52-Week change
-40.64%
Beta
1.86
50-Day moving average
0.94
200-Day moving average
1.05
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
0.00%
Operating margin
-649.00%
Operational effectiveness
Return on assets
-28.28%
Return on equity
-63.00%
Income statement
Revenue (ttm)
0.14
Revenue per share (ttm)
0.14
Quarterly revenue growth (yoy)
Gross profit (ttm)
0.00
EBITDA
-94,241,000.00
Net income to common (ttm)
-102,851,000.00
Diluted EPS (ttm)
-1.43
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
136.65M
Total cash per share (mrq)
2.27
Total debt (mrq)
27.13M
Total Debt/Equity (mrq)
22.03
Current ratio (mrq)
848.50%
Book value per share (mrq)
2.70
Cash flow
Cash flow statement
-87,839,000.00
Levered free cash flow (LFCF)
-43,455,876.00